The U.S. Food and Drug Administration is launching on April 25, 2019, its “Remove the Risk” campaign, aimed at promoting the safe disposal of unused opioids.
A new granule formulation of Prograf has been made available for the prophylaxis of organ rejection.
Milder strain of flu has been most common cause of cases this flu season
The current available influenza vaccine may have prevented substantial cases of influenza-associated adverse outcomes.
Investigators assessed the relationship between self-reported consumption of artificially sweetened beverages and stroke, coronary heart disease, and all-cause mortality in postmenopausal US women.
The use of aspirin was associated with a lower risk for cardiovascular events in individuals without cardiovascular disease.
An inverse dose-dependent association exists between cardiorespiratory fitness and type 2 diabetes risk.
The class I recall is being initiated because of incorrect assembly leading to catheter tube (lumens) reversal.
The ACIP and CDC have approved and released 2019 recommendations for the adult immunization schedule in the US.
Over 1400 clinical trials and research studies were reviewed by a panel of 13 experts to develop the new guideline.